Table 2.

Diagnoses, antisecretory medications and duration of dyspeptic symptoms prior to eradication therapy.

	Control (n = 38)	Intervention (n = 38)	P value
Diagnosis
Duodenal ulcer (DU)	15 (39.5%)	13 (34.2%)
Gastric ulcer (GU)	5 (13.1%)	2 (5.3%)
DU and GU	2 (5.3%)	5 (13.2%)
Duodenitis	8 (21.0%)	10 (26.3%)
Gastritis	2 (5.3%)	1 (2.6%)
Duodenitis and gastritis	6 (15.8%)	7 (18.4%)
Antisecretory medications used	38	38
Cimetidine	8	13
Lansoprazole	2	1
Nizatidine	5	6
Omeprazole	5	7
Ranitidine	18	11
Duration of antisecretory medication usage (months)
mean (± s.d.)	40.4 (± 5.6)	38.9 (± 3.9)	0.199§
range	18–72	12–96
Duration of dyspeptic symptoms (months)
median	48	46	0.412*
interquartile range	44.0–50.5	42.7–49.0

^§Student's t-test;

^*Mann–Whitney U-test.